Navigation Links
New tool better estimates pandemic threats
Date:3/5/2013

A simple new method better assesses the risks posed by emerging zoonotic viruses (those transmissible from animals to humans), according to a study published in PLOS Medicine this week. Dr. Simon Cauchemez and colleagues from Imperial College London in the UK and the Centers for Disease Control and Prevention in the US show that the new tool can produce transmissibility estimates for swine flu (the H3N2v-M virus), allowing researchers to better evaluate the possible pandemic threat posed by this virus. Until now, estimates of transmissibility were derived from detailed outbreak investigations, which are resource intensive and subject to selection bias. In this study, the authors develop a method to derive unbiased estimates of transmissibility with more limited data.

This study has important health policy implications because of the large numbers of people that could potentially be harmed by emerging viruses. Zoonotic viruses primarily cause occasional infections in human populations exposed to reservoir species (the animal species harboring the virus) because the pathogens are usually poorly adapted for sustained human-to-human transmission. However, zoonotic viruses are under strong selective pressure to acquire the ability for human-to-human transmission. Dr. Cauchemez and colleagues show that the novel approach described in this paper will be useful in assessing human-to-human transmissions during zoonotic outbreaks.

The researchers developed a mathematical model of disease transmission, which only requires data from routine surveillance and standard case investigations. They showed that the pandemic potential of a zoonotic virus could be estimated simply from the proportion of cases infected by the natural reservoir. The authors then applied their new approach to assess the human-to-human transmissibility of H1N1v, H1N2v and H3N2v viruses (in particular that of the H3N2v-M virus) from US surveillance data for the period December 2005 to December 2011 and Nipah virus in Malaysia and Bangladesh, as well as to a non-zoonotic pathogen Vibrio cholerae in the Dominican Republic. This study demonstrates the applicability of this novel approach to estimating the reproduction number R (or the number of individuals infected by a case), during zoonotic and certain non-zoonotic outbreaks.

The technique for estimating R described in this paper is simple and robust and does not require as much investigative effort as existing methods, say the authors. However, a key limitation of this new approach is that it is designed to estimate R during subcritical outbreaks. If it is not a subcritical outbreak, other methods are needed to estimate R.

Dr. Lyn Finelli, Surveillance and Outbreak Response Team (Influenza Division, CDC) and co-author on the paper said: "Outbreaks of the H3N2v-M virus largely took place at livestock exhibitions with thousands of visitors every day. It is very hard to perform detailed outbreak investigations and effectively trace cases in such settings since visitors are widely dispersed. The approach presented in the paper, is simple, requires few data, and was very useful in assessing transmissibility of the virus from the data available."


'/>"/>

Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
Public Library of Science
Source:Eurekalert

Related medicine news :

1. A better tool to diagnose tuberculosis
2. Job injuries among youth prompt calls for better safety standards
3. Students focus on creating a better cervical collar
4. Out-of-hand tree nut consumption associated with better diet quality in children and adults
5. Kidney cancer patients do better when whole kidney is not removed, U-M study shows
6. Kidney Cancer Patients Fare Better With Tumor Removal Only
7. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
8. Hispanics Seem to Have Better Odds of Lung Cancer Survival
9. Which ads are winners? Your brain knows better than you do
10. Better health in adulthood starts with early prevention in childhood
11. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Peter ... the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to Texas as a part of its national Swirl: A Wine Tasting Event ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American College of ... its recently formed Corporate Roundtable, a group of individuals and organizations whose collective ... , Canyon Ranch is a unique collection of lifestyle-based immersion vacation settings and ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American Board of Multiple ... for the discomforts and hidden dangers of foot fungus, particularly in the warm ... risk for developing fungal infections on the feet or toenails, the Board says. ...
(Date:9/19/2017)... ... September 19, 2017 , ... Leonard I. Linkow, DDS, DMSC, sets a new ... Xlibris on July of 2014). This book details the recent advances and techniques in ... benefit people who have lost all of their natural teeth . , In ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent review ... as the number one company for hearing aids, ranking it higher ... other brands. ... Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, state-of-the-art, ...
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 ... D.C. offering free MRI brain scans to the public.Where:  ... be parked at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology: